Brent Egan to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Brent Egan has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
2.398
-
Opportunities for improving cardiovascular health outcomes in adults younger than 65?years with guideline-recommended statin therapy. J Clin Hypertens (Greenwich). 2017 Sep; 19(9):850-860.
Score: 0.488
-
2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals. J Am Heart Assoc. 2016 08 19; 5(8).
Score: 0.465
-
Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network. Ther Adv Cardiovasc Dis. 2016 Apr; 10(2):56-66.
Score: 0.445
-
Impact of Implementing the 2013 ACC/AHA Cholesterol Guidelines on Vascular Events in a Statewide Community-Based Practice Registry. J Clin Hypertens (Greenwich). 2016 07; 18(7):663-71.
Score: 0.442
-
Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010. Circulation. 2014 May 20; 129(20):2052-61.
Score: 0.395
-
The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010. Hypertension. 2014 Nov; 64(5):997-1004.
Score: 0.101
-
Use of statins and blood pressure. Am J Hypertens. 2007 Sep; 20(9):937-41.
Score: 0.062